These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 30234179)

  • 1. The Kaplan-Meier Method for Estimating and Comparing Proportions in a Randomized Controlled Trial with Dropouts.
    Zee J; Xie SX
    Biostat Epidemiol; 2018; 2(1):23-33. PubMed ID: 30234179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis.
    Lueza B; Rotolo F; Bonastre J; Pignon JP; Michiels S
    BMC Med Res Methodol; 2016 Mar; 16():37. PubMed ID: 27025706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New methods for estimating follow-up rates in cohort studies.
    Xue X; Agalliu I; Kim MY; Wang T; Lin J; Ghavamian R; Strickler HD
    BMC Med Res Methodol; 2017 Dec; 17(1):155. PubMed ID: 29191174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaplan-Meier Survival Analysis Overestimates the Risk of Revision Arthroplasty: A Meta-analysis.
    Lacny S; Wilson T; Clement F; Roberts DJ; Faris PD; Ghali WA; Marshall DA
    Clin Orthop Relat Res; 2015 Nov; 473(11):3431-42. PubMed ID: 25804881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaplan-Meier curves for survivor causal effects with time-to-event outcomes.
    Chiba Y
    Clin Trials; 2013 Aug; 10(4):515-21. PubMed ID: 23610455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Landmark Estimation of Survival and Treatment Effect in a Randomized Clinical Trial.
    Parast L; Tian L; Cai T
    J Am Stat Assoc; 2014 Jan; 109(505):384-394. PubMed ID: 24659838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Landmark estimation of survival and treatment effects in observational studies.
    Parast L; Griffin BA
    Lifetime Data Anal; 2017 Apr; 23(2):161-182. PubMed ID: 26880366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interim analysis of binary outcome data in clinical trials: a comparison of five estimators.
    Lu QS; Chow SC; Tse SK
    J Biopharm Stat; 2019; 29(2):400-410. PubMed ID: 30599798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absolute risks rather than incidence rates should be used to estimate the number needed to treat from time-to-event data.
    Bender R; Kromp M; Kiefer C; Sturtz S
    J Clin Epidemiol; 2013 Sep; 66(9):1038-44. PubMed ID: 23790726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measures of follow-up in time-to-event studies: Why provide them and what should they be?
    Betensky RA
    Clin Trials; 2015 Aug; 12(4):403-8. PubMed ID: 26025565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A note on estimating treatment effect for time-to-event data in a literature-based meta-analysis.
    Hirooka T; Hamada C; Yoshimura I
    Methods Inf Med; 2009; 48(2):104-12. PubMed ID: 19283306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competing risk bias was common in Kaplan-Meier risk estimates published in prominent medical journals.
    van Walraven C; McAlister FA
    J Clin Epidemiol; 2016 Jan; 69():170-3.e8. PubMed ID: 26232083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IVF success corrected for drop-out: use of inverse probability weighting.
    Modest AM; Wise LA; Fox MP; Weuve J; Penzias AS; Hacker MR
    Hum Reprod; 2018 Dec; 33(12):2295-2301. PubMed ID: 30325421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaplan-Meier survival analysis overestimates cumulative incidence of health-related events in competing risk settings: a meta-analysis.
    Lacny S; Wilson T; Clement F; Roberts DJ; Faris P; Ghali WA; Marshall DA
    J Clin Epidemiol; 2018 Jan; 93():25-35. PubMed ID: 29045808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating cumulative live-birth rates after IVF treatment with Kaplan-Meier and competing risk methods.
    Viardot-Foucault V; Tai BC; Chen ZJ; Lim GH; Loh SF; Tan HH; Nadarajah S; Chan JK
    Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():41-6. PubMed ID: 26149478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic comparison of Kaplan-Meier proportions: monitoring a randomized clinical trial with a long-term binary endpoint.
    Brittain E; Follmann D; Yang S
    Biometrics; 2008 Mar; 64(1):189-97. PubMed ID: 17680830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival analysis using auxiliary variables via non-parametric multiple imputation.
    Hsu CH; Taylor JM; Murray S; Commenges D
    Stat Med; 2006 Oct; 25(20):3503-17. PubMed ID: 16345047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generalized estimating equations in cluster randomized trials with a small number of clusters: Review of practice and simulation study.
    Huang S; Fiero MH; Bell ML
    Clin Trials; 2016 Aug; 13(4):445-9. PubMed ID: 27094487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonparametric prediction of event times in randomized clinical trials.
    Ying GS; Heitjan DF; Chen TT
    Clin Trials; 2004; 1(4):352-61. PubMed ID: 16279273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating hazard ratios from published Kaplan-Meier survival curves: A methods validation study.
    Saluja R; Cheng S; Delos Santos KA; Chan KKW
    Res Synth Methods; 2019 Sep; 10(3):465-475. PubMed ID: 31134735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.